Leeward Investments’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Sell
164,327
-3,628
-2% -$308K 0.59% 64
2026
Q1
$14.5M Sell
167,955
-4,686
-3% -$421K 0.71% 59
2025
Q4
$15.1M Buy
172,641
+19,385
+13% +$1.47M 0.76% 48
2025
Q3
$8.78M Sell
153,256
-3,450
-2% -$199K 0.45% 103
2025
Q2
$9.25M Sell
156,706
-6,146
-4% -$397K 0.49% 92
2025
Q1
$11.9M Sell
162,852
-54,807
-25% -$4.53M 0.63% 69
2024
Q4
$18M Sell
217,659
-16,198
-7% -$1.28M 0.9% 34
2024
Q3
$16.7M Sell
233,857
-868
-0.4% -$61.3K 0.78% 46
2024
Q2
$16.1M Buy
234,725
+12,537
+6% +$749K 0.74% 48
2024
Q1
$11.9M Buy
222,188
+48,047
+28% +$2.58M 0.53% 96
2023
Q4
$9.28M Buy
174,141
+22,022
+14% +$1.07M 0.44% 110
2023
Q3
$7.55M Buy
+152,119
New +$8.51M 0.39% 122

Other funds holding GMED

Leeward Investments's GMED Position: Q2 2026 in Review

Leeward Investments reduced its Globus Medical (GMED) stake by 2.2% in Q2 2026, selling an estimated $308K and leaving 164,327 shares worth $13M. The position accounts for 0.59% of the portfolio, ranked #64.

Leeward Investments first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $18M in Q4 2024. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Leeward Investments held 164,327 shares of Globus Medical worth $13M as of Q2 2026.
  • Leeward Investments sold 3,628 Globus Medical shares in Q2 2026, an estimated $308K.
  • Globus Medical made up 0.59% of Leeward Investments's portfolio in Q2 2026, its #64 holding.
  • Leeward Investments first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Leeward Investments's Globus Medical position peaked at $18M in Q4 2024.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Leeward Investments's 13F filing for Q2 2026, filed 30 Jul 2026.